Replimune Group, Inc. (REPL)

2.86 +0.36 (+14.40%) USD  |  NASDAQ  |  May 04, 10:02
More

Replimune Group Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Phathom Pharmaceuticals, Inc. Upgrade
REGENXBIO, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade